Background. The second gas effect (SGE) is considered to be significant only during periods of large volume N 2 O uptake (VN 2 O); however, the SGE of small VN 2 O has not been studied. We hypothesized that the SGE of N 2 O on sevoflurane would become less pronounced when sevoflurane administration is started 60 min after the start of N 2 O administration when VN 2 O has decreased to $125 ml min
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Large volume N 2 O uptake (VN 2 O) during the early stages of N 2 O administration influences the increase of the alveolar fraction (FA) towards the inspired fraction (FI) of N 2 O itself (concentration effect) and that of a concomitantly administered potent inhaled anaesthetic (second gas effect, SGE). This results in a larger FA (larger FA/FI) and a more rapid rate of increase [larger d(FA/FI)/dt]. 1 2 Both the concentration effect and the SGE are traditionally explained by the concentrating effect and augmented inspired ventilation (increased tracheal inflow). 3 While limitations of the classical diagram explaining the SGE on potent inhaled anaesthetics have been highlighted (e.g. the importance of the mode of ventilation) and some refinements have been suggested, 4 5 there seems to be agreement that the SGE is significant only during periods of large VN 2 O. The magnitude and time course of the concentration and SGE relative to the uptake pattern of N 2 O has not been examined. We therefore hypothesized that (i) the SGE of N 2 O on sevoflurane would be most pronounced when ) were treated with ephedrine (5 mg) or atropine (0.5 mg), respectively.
All data were collected using a single ADU anaesthesia workstation with a single vaporizing (Aladin Ò ) cassette in the same operating room with the same agent analyser. The Datex-Ohmeda Compact Block was used, a patented part of the circle system containing inspiratory and expiratory valves, FGF connection and a small disposable canister containing soda lime. Because the volume of this circle system is only 3.4 litre, the wash-in time constant of the system (circle system+functional residual capacity of 2.0 litre) is <1 min when using a FGF of 6 litre min À1 . By electronically compensating for compression volume and circuit compliance and by using FGF compensation, the actual inspired tidal volume matches the set tidal volume. Inspired and expired gases were sampled between the tracheal tube and heat and moisture exchanger and analysed by a multi-gas analyser (Datex-Engstrom Compact Airway Module M-CAiOV, Datex-Engstrom, Helsinki, Finland; accuracy for sevoflurane ±0.2%) that was calibrated each morning. Gases sampled by the agent analyser were not redirected to the anaesthesia circuit. Inspired and expired gas concentrations were automatically downloaded in a spreadsheet every 10 s.
FA/FI was directly calculated from the data every 10 s, and the area under the curve (AUC) (from 0 to 15 min) was calculated to compare the groups (SigmaPlot 2002 for Windows Version 8.02, SPSS Inc., Chicago, IL). This methodology is similar to that described by Taheri and Eger, 7 except that they used the area above the curve (1ÀFA/FI) and ignored the first minute because they assumed that this mainly represents lung wash-in. Patient characteristics, MAP, HR and the AUCs of FA/FI in the six groups were compared using ANOVA followed by Student NewmanKeuls test. P<0.05 was considered statistically significant. Data are presented as mean (SD) and the incidence of observations unless indicated otherwise.
Results
Patient characteristics (Table 1) were identical in all groups. One patient in the 2 min N 2 O group was deleted because the hyperdynamic response after intranasal epinephrine injection led to an entirely different FA/FI over time curve. The 1.8% sevoflurane in O 2 group needed more additional sufentanil boluses. MAP and HR (Table 2) were not different except for a lower HR at 0 min in the N 2 O 60 min group (P<0.05).
The sevoflurane FA/FI patterns were similar in all the groups except between 0 and 4 min in the 1.8% sevoflurane in O 2 group. The sevoflurane FA/FI was larger in the N 2 O groups than in the O 2 groups, and was identical in all four N 2 O groups and in both O 2 groups (Table 1 and Figs 1 and 2). Figure 1 shows only the mean data for clarity, and Figure 2 shows the results of only the N 2 O 5 min, N 2 O 60 min, and 3.6% sevoflurane in O 2 groups, with the 95% confidence intervals (=standard error of the mean·1.96).
Discussion
We found that N 2 O clearly exerts a SGE on sevoflurane: FA/FI of sevoflurane was larger in the N 2 O groups than in the O 2 groups. At first sight, these observations are compatible with the classical model of the SGE. According to this model, large amounts of VN 2 O result in a concentrating effect and augmented inspired ventilation. These mechanisms have been didactically presented by a graphical 'box' approach, which also allows the calculation of the expected SGE. 4 5 8 In our study, only the concentrating effect could have contributed to a SGE because CMV was used without any attempt at keeping the end-expired carbon The second gas effect of N 2 O on sevoflurane dioxide constant ('constant inspired ventilation'). 8 Augmented inspired ventilation can only occur during spontaneous ventilation ('constant outflow'), because during CMV no additional gases can be drawn into the lungs during inspiration, and VN 2 O will therefore cause a decrease in expired ventilation and consequently an increase in Fa CO 2 . We now could calculate the expected magnitude of the SGE in, for example, the 5 min N 2 O group using the classical graphical representation. 3 In this group VN 2 O is very large at the moment sevoflurane is started and therefore would be expected to result in a large SGE. At the time the sevoflurane vaporizer is set at 1.8%, VN 2 O is $450 ml min À1 according to the Severinghaus formula (VN 2 O at an FA of 65% is 1000/Ht ml min À1 , with t=anaesthesia duration). 6 9 With a TV of 500 ml and a ventilatory frequency of 10, there is 45 ml uptake of N 2 O per breath. If FRC is 2000 ml, the FRC would be expected to be reduced by $2.25%, hence the concentrating effect is calculated to increase FA sevo by $2.25%. However, with the same FI, we found that the FA/FI of sevoflurane was 10 and 12% larger than in the 1.8% sevoflurane in O 2 and 3.6% sevoflurane in O 2 groups 5 min after the start of sevoflurane, respectively. Note that this calculation even ignores the decrease in VN 2 O that occurs between 5 and 10 min after the start of N 2 O administration, and therefore may be a high estimate of the concentrating effect. So even after 10 min of N 2 O administration, the SGE is more pronounced than the classical model would suggest. This means that the graphical representation of the SGE fails to predict the magnitude of the SGE. Similarly, the use of more elaborate versions of the graphical representation of the SGE fail to accurately predict the magnitude of the SGE. 4 On the contrary, Korman and Mapleson 4 suggest that the SGE is more pronounced with the constant inspired ventilation scenario, quite the opposite of what is currently accepted. 7 We also found that the magnitude of the SGE of N 2 O on the FA/FI of sevoflurane was similar during small and large VN 2 O as indicated by the similar FA/FI of sevoflurane in all the N 2 O groups (where sevoflurane was administered 0, 2, 5 and 60 min after the start of N 2 O administration). In addition, the FA/FI in the 60 min N 2 O group was larger than that in the O 2 groups, indicating that small VN 2 O ($125 ml min À1 ) still has a clearly measurable SGE. The demonstration of a SGE when VN 2 O is small ($100 ml min À1 ) is a new finding. It is obvious that the classical model of the SGE fails to explain these two observations. We cannot exclude that with the use of spontaneous respiration (allowing augmented inspired ventilation) and a more precise determination method of the concentration of the gases using gas chromatography a difference could be demonstrated between the early and late N 2 Could N 2 O increase FA/FI by lowering the blood solubility of sevoflurane? Even though a plausible explanation, studies examining the effect of N 2 O on blood solubility of potent inhaled anaesthetics are conflicting. N 2 O has been reported to increase blood solubility of isoflurane by $5%. 15 However, a more recent study found no effect of N 2 O on the blood solubility of neither isoflurane nor sevoflurane. 16 In conclusion, our observations suggest that during constant inspired ventilation the classical model of the SGE alone, including the graphical representation, cannot be used to explain all aspects of the SGE nor quantify its effects. The main value of the graphical representation of the SGE is to illustrate its concept and to make it intuitively acceptable. We speculate that changes in lung ventilation/ perfusion inhomogeneity caused by general anaesthesia result in a concentrating and thus a SGE of N 2 O on sevoflurane, and this at VN 2 O levels previously considered by most to be too small to exert a second gas effect.
